Table 2.
Ref. | Country | No. of patients | Type of study | Patients with HBsAg mutation, n (%) | Clinical significance | HBsAg mutation |
Sticchi et al[77] | Italy | 256 | Cross-sectional | 8 (3.1) | Detection failure; vaccine escape | G145R, T126I |
Luongo et al[79] | Italy | 1 | Case report | 1 | Vaccine escape | M125T, T127P Q129H |
Lee et al[66] | South Korea | 1 | Case report | 1 | Vaccine escape | G145R, P120Q, I126T |
Seddigh-Tonekaboni et al[68] | United Kingdom | 4 | 2 | Vaccine escape | P142S, G145R, G145A | |
Ngui et al[73] | England, Wales | 17 | Cross-sectional | 2 (12) | Vaccine escape | P120Q, F134Y, D144A, I126N |
Carman et al[62] | Multinational | 32 | Cross-sectional | 1 | Vaccine escape | G145R |
Laoi et al[78] | Ireland | 32 | Cross-sectional | 6 (18.5) | Vaccine escape, detection failure | G145A, F134L, D144E, S143L |
Foy et al[80] | United States | 1 | Case report | 1 | Immune escape | D144E |
HBsAg: Hepatitis B surface antigen.